| Code | 3894E | ||||||||||
| MA number | 07/0141/23-S | ||||||||||
| Product Form: | tbl 50x500 mg (blis.PVC/Al-jednodáv.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Medreg s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.06.2023 |
| Validity: | 22.06.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Dokument: |
DHPC_metamizol_06.12.2024.pdf
|
| SPC: |
SPC_Metamizol Medreg_11.2024.pdf
|
| PIL: |
PIL_Metamizol Medreg_11.2024.pdf
|
| Safety feature | Yes |
| Data update: | 29.06.2023 |
